regenerative cell induction program (LoneStar Heart)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameregenerative cell induction program (LoneStar Heart)
Drug Alias Nameinduced pluripotent stem cells (LoneStar Heart)cardiac reprogramming therapy (LoneStar Heart)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionTranscription factors stimulants
TargetsTranscription factors
Therapy Area/IndicationsMyocardial IschemiaHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Texas Southwestern Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLonestar Heart IncUniversity of Texas Southwestern Medical Center
Active IndicationsN/A
Inactive IndicationsMyocardial IschemiaHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A